Human / Cynomolgus Activin RIIA / ACVR2A Protein, His Tag, low endotoxin (MALS & SPR verified)
Cat. No. ACA-H5243
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| LAE-102 | LAE-102 | Phase 2 Clinical | Laekna Therapeutics Shanghai Co Ltd | Carcinoma, Non-Small-Cell Lung; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Overweight; Solid tumours | Details |
| SSS-67 | SSS67; SSS-67 | Phase 1 Clinical | Shenyang Sunshine Pharmaceutical Co Ltd | Obesity; Overweight | Details |
| JMT-206 | JMT206; JMT-206 | Phase 1 Clinical | Shanghai Jmt-Bio Inc | Body Weight; Obesity; Overweight; Sarcopenia | Details |
| IMC-003(ImmuneOnco Biopharmaceuticals) | IMM72; IMM-72; IMC-003; IMC-003(ImmuneOnco Biopharmaceuticals) | Phase 1 Clinical | Pulmonary Arterial Hypertension | Details |

